Necl 4 and RNase 5 Are Important Biomarkers for Gastric and Colon Adenocarcinomas

Creative Commons License

SAYAR İ., GÖKÇE A., DEMİRTAŞ L., Eken H., Cimen F. K., ÇİMEN O.

MEDICAL SCIENCE MONITOR, cilt.23, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23
  • Basım Tarihi: 2017
  • Doi Numarası: 10.12659/msm.902648
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Erzincan Binali Yıldırım Üniversitesi Adresli: Evet

Özet

Background: There is a need to identify new prognostic factors that may be used in addition to the known risk factors in gastrointestinal adenocarcinomas. In this study, we aimed to determine the expression of Necl 4 and RNase 5 biomarkers in gastric and colon adenocarcinomas, as well as the prognostic efficacy of these biomarkers in gastric and colon adenocarcinomas.